Prostatic Neoplasms, Castration-Resistant trials recruiting in California

All Prostatic Neoplasms, Castration-Resistant trials nationally

Cities in California

Recruiting trials in California

• 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
  NCT06706921 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male · California: Los Angeles
• 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
  NCT04868604 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · California: Stanford
• A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT07719361 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: Los Angeles
• A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
  NCT07225946 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Fountain Valley, La Jolla, Los Alamitos, Los Angeles
• Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
  NCT06353386 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: La Jolla, Los Angeles